Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Shima

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Developmental Cell|September 2, 2014
Differential apicobasal VEGF signaling at vascular blood-neural barriersNatalie Hudson, Michael B Powner, Mosharraf H Sarker, et al.
Developmental Biology|June 23, 2020
Macrophages fine-tune pupil shape during developmentMoe Takahashi, Mika Misaki, Shinsuke Shibata, et al.
The Journal of Experimental Medicine|August 6, 2003
VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularizationSusumu Ishida, Tomohiko Usui, Kenji Yamashiro, et al.
Journal of the American Society of Nephrology : JASN|March 16, 2022
Reduced Glomerular Filtration in Diabetes Is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell FenestrationsNatalie C Finch, Sarah S Fawaz, Chris R Neal, et al.
Cancer Research|April 3, 2008
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumorsGillian M Tozer, Simon Akerman, Neil A Cross, et al.
EMBO Molecular Medicine|May 2, 2019
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseasesJörg T Regula, Peter Lundh von Leithner, Richard Foxton, et al.
EMBO Molecular Medicine|May 24, 2017
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseasesJörg T Regula, Peter Lundh von Leithner, Richard Foxton, et al.
EMBO Molecular Medicine|October 16, 2016
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseasesJörg T Regula, Peter Lundh von Leithner, Richard Foxton, et al.
The Journal of Experimental Medicine|February 16, 2018
Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormalityIl-Kug Kim, Kangsan Kim, Eunhyeong Lee, et al.
Circulation Research|February 21, 2020
Dll4 Suppresses Transcytosis for Arterial Blood-Retinal Barrier HomeostasisJee Myung Yang, Chan Soon Park, Soo Hyun Kim, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Developmental Cell|September 2, 2014
Differential apicobasal VEGF signaling at vascular blood-neural barriersNatalie Hudson, Michael B Powner, Mosharraf H Sarker, et al.
Developmental Biology|June 23, 2020
Macrophages fine-tune pupil shape during developmentMoe Takahashi, Mika Misaki, Shinsuke Shibata, et al.
The Journal of Experimental Medicine|August 6, 2003
VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularizationSusumu Ishida, Tomohiko Usui, Kenji Yamashiro, et al.
Journal of the American Society of Nephrology : JASN|March 16, 2022
Reduced Glomerular Filtration in Diabetes Is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell FenestrationsNatalie C Finch, Sarah S Fawaz, Chris R Neal, et al.
Cancer Research|April 3, 2008
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumorsGillian M Tozer, Simon Akerman, Neil A Cross, et al.
EMBO Molecular Medicine|May 2, 2019
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseasesJörg T Regula, Peter Lundh von Leithner, Richard Foxton, et al.
EMBO Molecular Medicine|May 24, 2017
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseasesJörg T Regula, Peter Lundh von Leithner, Richard Foxton, et al.
EMBO Molecular Medicine|October 16, 2016
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseasesJörg T Regula, Peter Lundh von Leithner, Richard Foxton, et al.
The Journal of Experimental Medicine|February 16, 2018
Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormalityIl-Kug Kim, Kangsan Kim, Eunhyeong Lee, et al.
Circulation Research|February 21, 2020
Dll4 Suppresses Transcytosis for Arterial Blood-Retinal Barrier HomeostasisJee Myung Yang, Chan Soon Park, Soo Hyun Kim, et al.
Pageof 5